Feedback / Questions
ALZ002 - AnnJi Pharma, Fortress
https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-for-aj201-a-first-in-class-therapy-for-kenndys-disease-302592255.html
Oct 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next